ALGi's vision is to develop customized herbal supplements using an engineered algal strain. Their initial proof of concept product, HeadSooth, contains salicylic acid for pain relief and is part of a $2 billion aspirin market. Future products will target conditions like joint pain, blood sugar control, stomach upset, sleep issues, and malaria using compounds like curcumin, cinnamaldehyde, gingerol, and quinine. ALGi plans to partner with organizations like the NHS, WHO, and charities to bring these affordable herbal supplements to the general population.